A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

Protocol No

DERM-INCYTE-INCB018424-325

Staff Member

Gretchen M. Roth

Phase

III

Summary

This study is being done to compare the safety and effects of a Study Cream called ruxolitinib with a vehicle cream on people with hidradenitis suppurativa.

Objective

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

Status

OPEN TO ACCRUAL